STXBP1 and SYNGAP1 Related Disorders Natural History Study

计划入组 600 人 · 首次发布于 2024 年 8 月 15 日

Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1

计划入组 16 人 · 首次发布于 2003 年 8 月 25 日

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4

首次发布于 1999 年 9 月 21 日

SYNGAP1

STXBP1-Related Disorders(Encoded)

Opioid-related disorders gene therapy (Copernicus Therapeutics)

Alzheimer's Disease And Related Disorders Association, Inc.

United States

Alzheimer's Disease And Related Disorders Association, Georgia Chapter, Inc.

United States

Institute For Neurodegenerative Disorders

United States

Gene Therapy Shows Promise for SYNGAP1-Related Brain Disorders in Preclinical Study

CAMP4 Therapeutics Advances SYNGAP1 Gene Therapy Toward Clinical Testing with GLP Toxicology Studies

CAMP4 Therapeutics Secures $100 Million Financing to Advance First-in-Class SYNGAP1 Treatment